NCM Boston

NCM Boston

Subscribe

Oxford Nanopore Technologies

Michael Dean

.
Job title
Institution
National Cancer Institute, USA
Biography

Michael Dean is a senior investigator in the Laboratory of Translational Genomics. He obtained his PhD from the Biochemistry Department at the Boston University School of Medicine. He performed his postdoctoral studies at the National Cancer Institute, Center for Cancer Research (CCR), on the MET oncogene and cystic fibrosis gene. He is a member of the American Society of Human Genetics, the American Association of Cancer Research, and the Human Genome Organization (HUGO), and is an adjunct faculty member at Hood College. In 2022, Dr. Dean received the Hubert H. Humphrey Award for Service to America.

Recent publications

Ayse, K. et al. Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads. medRxiv 2024.03.22.24304756 (2024).
DOI: 10.1101/2024.03.22.24304756

Rodriguez, I. et al. Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing. Am J Hum Genet. 111(3):544–561 (2024).
DOI: 10.1016/j.ajhg.2024.01.002

Talks at this conference

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag